Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.

The Prostate - 1 Dec 2005

Fromont Gaëlle, Valeri Antoine, Cher Michael, Pontes Jose Edson, Vallancien Guy, Validire Pierre, Latil Alain, Cussenot Olivier

Abstract excerpt

PURPOSE: Loss of heterozygosity (LOH) at 16q23.2 is an early and frequent event in prostate cancer. LOH is thought to be involved in tumor development and progression mainly through inactivation of tumor suppressor genes. However, it has been demonstrated that LOH at 16q23.2 is an independent marker of good prognosis in breast cancer. In the present study, we evaluated the clinical relevance of 16q23.2 LOH in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human, Pair 16
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Loss of Heterozygosity

Share to Microsatellite Repeats

Share to Predictive Value of Tests

Share to Proportional Hazards Models

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 16015610
DOI: 10.1002/pros.20304

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.PMID 16015610Read ↗

Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient.Semantic proximity Read ↗

Allelic loss on chromosomes 8p, 22q and 18q (DCC) in human prostate cancer.Semantic proximity Read ↗

Allelic loss of chromosomes 16q and 10q in human prostate cancer.Semantic proximity Read ↗

Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.Semantic proximity Read ↗

Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancerSemantic proximity Read ↗

Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.Semantic proximity Read ↗

Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancerSemantic proximity Read ↗

Allelic imbalance mapping of chromosome 16 shows two regions of common deletion in prostate adenocarcinoma.Semantic proximity Read ↗

Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.Semantic proximity Read ↗

BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer.Semantic proximity Read ↗

ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.Semantic proximity Read ↗

Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.